A 1-year-old girl with a gain-of-function STAT1 mutation treated with hematopoietic stem cell transplantation

Journal of Clinical Immunology

Volumn 33, Issue 8, 2013, Pages 1273-1275

  Aldave, Juan Carlos ^a   Cachay, Enrique ^a   Núñez, Luis ^a   Chunga, Ausberto ^a   Murillo, Sergio ^a   Cypowyj, Sophie ^b   Bustamante, Jacinta ^c,d   Puel, Anne ^c   Casanova, Jean Laurent ^b,c,d   Koo, Armando ^a  

^a HOSPITAL NACIONAL EDGARDO REBAGLIATI MARTINS   (Peru)

^b ROCKEFELLER UNIVERSITY   (United States)

^c IMAGINE INSTITUTE   (France)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; CYCLOSPORIN; FLUDARABINE; IMMUNOGLOBULIN; ITRACONAZOLE; MELPHALAN; METHOTREXATE; POSACONAZOLE; STAT1 PROTEIN; THYMOCYTE ANTIBODY;

ANTIBIOTIC RESISTANCE; ARTICLE; CANDIDIASIS; CASE REPORT; CHILD; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DIARRHEA; DNA BINDING; DYSPHONIA; ESCHERICHIA COLI; FECES ANALYSIS; FEMALE; GAIN OF FUNCTION MUTATION; GENE; GENE LOCATION; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HETEROZYGOSITY; HUMAN; KLEBSIELLA PNEUMONIAE; LARYNX DISORDER; LUNG INFILTRATE; PRESCHOOL CHILD; PRIORITY JOURNAL; STAT1 GENE; THORAX RADIOGRAPHY;

ANTIFUNGAL AGENTS; CANDIDIASIS, ORAL; CHRONIC DISEASE; FATAL OUTCOME; FEMALE; GENES, DOMINANT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; LUNG DISEASES, INTERSTITIAL; MUTATION; RECURRENCE; STAT1 TRANSCRIPTION FACTOR; THROMBOCYTOPENIA; TRANSPLANTATION CONDITIONING;

EID: 84889053021     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-013-9947-5     Document Type: Article

References (19)

1. Al-Herz W, Bousfiha A, Casanova JL, Chapel H, Conley ME, Cunningham-Rundles C, et al. Primary immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency. Front Immunol. 2011;2:1-26.
2. Liu L, Okada S, Kong XF, Kreins AY, Cypowyj S, Abhyankar A, et al. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J Exp Med. 2011;208:1635-48.
3. Engelhardt K, Grimbacher B. Mendelian traits causing susceptibility to mucocutaneous fungal infections in human subjects. J Allergy Clin Immunol. 2012;129:294-305.
4. Puel A, Cypowyj S, Maródi L, Abel L, Picard C, Casanova JL. Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis. Curr Opin Allergy Clin Immunol. 2012;12:616-22.
5. van de Veerdonk FL, Plantinga TS, Hoischen A, Smeekens SP, Joosten LA, Gilissen C, et al. STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis. N Engl J Med. 2011;365:54-61.
6. Hori T, Ohnishi H, Teramoto T, Tsubouchi K, Naiki T, Hirose Y, et al. Autosomal-dominant chronic mucocutaneous candidiasis with STAT1-mutation can be complicated with chronic active hepatitis and hypothyroidism. J Clin Immunol. 2012;32:1213-20.
7. Puel A, Cypowyj S, Bustamante J, Wright JF, Liu L, Lim HK, et al. Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Science. 2011;332:65-8.
8. Boisson-Dupuis S, Kong XF, Okada S, Cypowyj S, Puel A, Abel L, et al. Inborn errors of human STAT1: allelic heterogeneity governs the diversity of immunological and infectious phenotypes. Curr Opin Immunol. 2012;24:364-78.
9. Hoh MC, Lin HP, Chan LL, Lam SK. Successful allogeneic bone marrow transplantation in severe chronic mucocutaneous candidiasis syndrome. Bone Marrow Transplant. 1996;18:797-800.
10. Deeg HJ, Lum LG, Sanders J, Levy GJ, Sullivan KM, Beatty P, et al. Severe aplastic anemia associated with chronic mucocutaneous candidiasis. Immunologic and hematologic reconstitution after allogeneic bone marrow transplantation. Transplantation. 1986;41:583-6.
11. Al Rushood M, McCusker C, Mazer B, Alizadehfar R, Grimbacher B, Depner M, et al. Autosomal dominant cases of chronic mucocutaneous candidiasis segregates with mutations of signal transducer and activator of transcription 1, but not of toll-like receptor 3. J Pediatr. 2013. doi: 10.1016/j.jpeds.2013.02.040.
12. Hori T, Ohnishi H, Teramoto T, Tsubouchi K, Naiki T, Hirose Y, et al. Autosomal-dominant chronic mucocutaneous candidiasis with STAT1-mutation can be complicated with chronic active hepatitis and hypothyroidism. J Clin Immunol. 2012;32(6):1213-20. doi: 10.1007/s10875-012-9744-6.
13. Romberg N, Morbach H, Lawrence MG, Kim S, Kang I, Holland SM, et al. Gain-of-function STAT1 mutations are associated with PD-L1 overexpression and a defect in B-cell survival. J Allergy Clin Immunol. 2013. doi: 10.1016/j.jaci.2013.01.004.
14. Sampaio EP, Hsu AP, Pechacek J, Bax HI, Dias DL, Paulson ML, et al. Signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations and disseminated coccidioidomycosis and histoplasmosis. J Allergy Clin Immunol. 2013. doi: 10.1016/j.jaci.2013.01.052.
15. Smeekens SP, Plantinga TS, van de Veerdonk FL, Heinhuis B, Hoischen A, Joosten LA, et al. STAT1 hyperphosphorylation and defective IL12R/IL23R signaling underlie defective immunity in autosomal dominant chronic mucocutaneous candidiasis. PLoS One. 2011;6(12):e29248. doi: 10.1371/journal.pone.0029248.
16. Takezaki S, Yamada M, Kato M, Park MJ, Maruyama K, Yamazaki Y, et al. Chronic mucocutaneous candidiasis caused by a gain-of-function mutation in the STAT1 DNA-binding domain. J Immunol. 2012;189:1521-6.
17. Tóth B, Méhes L, Taskó S, Szalai Z, Tulassay Z, Cypowyj S, et al. Herpes in STAT1 gain-of-function mutation. Lancet. 2012;379:2500.
18. Uzel G, Sampaio EP, Lawrence MG, Hsu AP, Hackett M, Dorsey MJ, et al. Dominant gain-of-function STAT1 mutations in FOXP3 wild-type immune dysregulation-polyendocrinopathy-enteropathy-X-linked-like syndrome. J Allergy Clin Immunol. 2013. doi: 10.1016/j.jaci.2012.11.054.
19. Wang X, Lin Z, Gao L, Wang A, Wan Z, Chen W, et al. Exome sequencing reveals a signal transducer and activator of transcription 1 (STAT1) mutation in a child with recalcitrant cutaneous fusariosis. J Allergy Clin Immunol. 2013;131:1242-3.